Durvalumab and olaparib combination extends survival in advanced endometrial cancer
Updated Phase 3 DUO-E trial results presented at ESMO 2026 show that durvalumab plus olaparib after chemotherapy achieved a median ...
Tag: pMMR tumors
POPULAR NEWS
-
Ginsenoside RK3 triggers ferroptosis in osteosarcoma cells and boosts doxorubicin response
-
Durvalumab and olaparib combination extends survival in advanced endometrial cancer
-
Sleep Academy Issues New Guideline for Treating Shift Work Disorder
-
Aging Immune Signal Identified as a Conserved Brake on Nerve Regeneration